Bristol-Myers Squibb competitorsClear all

Bristol-Myers Squibb's top competitors include AstraZeneca, Eli Lilly, Novartis, Edwards Lifesciences, Merck Group, AbbVie, Johnson & Johnson, Pfizer, Catalent and Lonza.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Eli Lilly
Eli Lilly
Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of products in the pharmaceutical business segment.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets a range of healthcare products.
Edwards Lifesciences
Edwards Lifesciences
Edwards Lifesciences is a company operating as a global provider of patient-focused medical solutions for structural heart disease and critical care monitoring.
Merck Group
Merck Group
Merck Group is a pharmaceutical, chemical, and life sciences company.
AbbVie
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Catalent
Catalent
Catalent (also known as Catalent Pharma Solutions) is a company providing integrated services, drug delivery technologies, and manufacturing solutions.
Lonza
Lonza
Lonza (also known as Lonza Biologics) is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries.
Founding Date
Founding Date
1887
Founding Date
1999
Founding Date
1876
Founding Date
1996
Founding Date
1958
Founding Date
1668
Founding Date
2013
Founding Date
1886
Founding Date
1849
Founding Date
2007
Founding Date
1897
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Braine L'alleud, BE
Montréal, CA
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Cambridge, GB HQ
Algiers, DZ
Tizi Ouzou, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
see more
Locations
Indianapolis, US HQ
Sydney, AU
Melrose Park, AU
Wien, AT
Charlottetown, CA
Toronto, CA
Baoding, CN
see more
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Irvine, US HQ
Macquarie Park, AU
Wien, AT
Dilbeek, BE
São Paulo, BR
Mississauga, CA
Shanghai, CN
see more
Locations
Darmstadt, DE HQ
Tirana, AL
Buenos Aires, AR
Frenchs Forest, AU
Wien, AT
Manama, BH
Overijse, BE
see more
Locations
Lake Bluff, US HQ
Alger, DZ
Buenos Aires, AR
Mascot, AU
Wien, AT
Wavre, BE
Sarajevo, BA
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Yerevan, AM
Ultimo, AU
Wien, AT
Minsk, BY
Beerse, BE
see more
Locations
New York, US HQ
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
Kirkland, CA
see more
Locations
Franklin Township, US HQ
Loma Hermosa, AR
Braeside, AU
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Locations
Basel, CH HQ
Ingeniero Maschwitz, AR
Brooklyn, AU
Derrimut, AU
Mount Waverley, AU
Verviers, BE
São Paulo, BR
see more
Employees
Employees
30,00029% increase
Employees
70,6009% increase
Employees
33,62513% decrease
Employees
103,91417% decrease
Employees
13,9009% increase
Employees
52,1401% increase
Employees
30,000
Employees
132,2002% decrease
Employees
88,3004% decrease
Employees
12,30015% increase
Employees
15,4685% increase
Valuation ($)
Valuation ($)
136.5 b
Valuation ($)
143.7 b
Valuation ($)
144.7 b
Valuation ($)
N/A
Valuation ($)
44.8 b
Valuation ($)
49.5 b
Valuation ($)
158.7 b
Valuation ($)
382 b
Valuation ($)
207.8 b
Valuation ($)
11.4 b
Valuation ($)
N/A
Twitter followers
Twitter followers
141.8 k
Twitter followers
176.4 k
Twitter followers
69
Twitter followers
268.7 k
Twitter followers
8.3 k
Twitter followers
17.6 k
Twitter followers
62.8 k
Twitter followers
196.7 k
Twitter followers
18.2 k
Twitter followers
18.4 k
Twitter followers
6.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
55
Number of tweets (last 30 days)
27
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
31
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
92
Number of tweets (last 30 days)
47
Number of tweets (last 30 days)
96
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
100
Number of tweets (last 30 days)
7
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
19.5
Average likes per tweet (last 30 days)
144.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
14.3
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
18.4
Average likes per tweet (last 30 days)
15.2
Average likes per tweet (last 30 days)
12.3
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
13
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
64.52%
Percentage of tweets with engagement (last 30 days)
91.67%
Percentage of tweets with engagement (last 30 days)
94.57%
Percentage of tweets with engagement (last 30 days)
95.74%
Percentage of tweets with engagement (last 30 days)
81.25%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
81%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
133722
Alexa Website Rank
120297
Alexa Website Rank
166332
Alexa Website Rank
138421
Alexa Website Rank
209258
Alexa Website Rank
89870
Alexa Website Rank
129532
Alexa Website Rank
28232
Alexa Website Rank
33553
Alexa Website Rank
303118
Alexa Website Rank
259214
Employee Rating
Employee Rating
3.9
Employee Rating
3.9
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
3.9
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
4.0
Employee Rating
4.0
Employee Rating
3.0
Employee Rating
3.2

Financial

Revenue (est.)
Revenue (est.)
$26.1b (FY, 2019)
Revenue (est.)
$24.4b (FY, 2019)
Revenue (est.)
$22.3b (FY, 2019)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
$4.3b (FY, 2019)
Revenue (est.)
€14.8b (FY, 2018)
Revenue (est.)
$33.3b (FY, 2019)
Revenue (est.)
$82.1b (FY, 2019)
Revenue (est.)
$51.8b (FY, 2019)
Revenue (est.)
$2.5b (FY, 2019)
Revenue (est.)
CHF5.9b (FY, 2019)
Cost of goods
Cost of goods
$8.1b (FY, 2019)
Cost of goods
$4.9b (FY, 2019)
Cost of goods
$4.7b (FY, 2019)
Cost of goods
$17.2b (FY, 2017)
Cost of goods
$1.1b (FY, 2019)
Cost of goods
€5.4b (FY, 2018)
Cost of goods
$7.4b (FY, 2019)
Cost of goods
$27.6b (FY, 2019)
Cost of goods
$10.2b (FY, 2019)
Cost of goods
$1.7b (FY, 2019)
Cost of goods
CHF3.7b (FY, 2019)
Gross profit
Gross profit
$18.1b (FY, 2019)
Gross profit
$19.5b (FY, 2019)
Gross profit
$17.6b (FY, 2019)
Gross profit
$31.9b (FY, 2017)
Gross profit
$3.2b (FY, 2019)
Gross profit
€9.5b (FY, 2018)
Gross profit
$25.8b (FY, 2019)
Gross profit
$54.5b (FY, 2019)
Gross profit
$41.5b (FY, 2019)
Gross profit
$805.1m (FY, 2019)
Gross profit
CHF2.3b (FY, 2019)
Net income
Net income
$3.4b (FY, 2019)
Net income
$1.2b (FY, 2019)
Net income
$8.3b (FY, 2019)
Net income
$7.7b (FY, 2017)
Net income
$1b (FY, 2019)
Net income
€3.4b (FY, 2018)
Net income
$7.9b (FY, 2019)
Net income
$15.1b (FY, 2019)
Net income
$16.3b (FY, 2019)
Net income
$137.4m (FY, 2019)
Net income
CHF646m (FY, 2019)

Operating

Countries
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
60 (FY, 2018)
Countries
125 (FY, 2017)
Countries
80 (FY, 2019)
Countries
30 (FY, 2018)
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
7 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
97 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing and R&D Facilities
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
14 (FY, 2018)
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
N/A
Manufacturing and R&D Facilities
70 (FY, 2018)
Patents and Patent Applications
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
4.7 k (FY, 2019)
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
1.3 k (FY, 2019)
Patents and Patent Applications
N/A
Patients Included in Clinical Trials
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
33 k (FY, 2017)
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
104 k (FY, 2018)
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Phase III Trials Products
Phase III Trials Products
8 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
19 (FY, 2016)
Phase III Trials Products
37 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
29 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
167 (FY, 2019)
Projects in R&D Pipeline
66 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
51 k (FY, 2018)
Suppliers
3.5 k (Jun, 2018)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A

Funding

Total funding raised
Total funding raised
$ 15.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

AstraZeneca
HQ
Cambridge, GB
Employees
70,600↑ 9% increase

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company
Eli Lilly
HQ
Indianapolis, US
Employees
33,625↓ 13% decrease

Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of products in the pharmaceutical business segment.

View company
Novartis
HQ
Basel, CH
Employees
103,914↓ 17% decrease

Novartis is a company that researches, develops, manufactures, and markets a range of healthcare products.

View company
Edwards Lifesciences
HQ
Irvine, US
Employees
13,900↑ 9% increase

Edwards Lifesciences is a company operating as a global provider of patient-focused medical solutions for structural heart disease and critical care monitoring.

View company